284 related articles for article (PubMed ID: 20016534)
41. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt.
Settin A; Al Haggar M; Al Dosoky T; Al Baz R; Abdelrazik N; Fouda M; Aref S; Al-Tonbary Y
Hematology; 2007 Apr; 12(2):103-11. PubMed ID: 17454190
[TBL] [Abstract][Full Text] [Related]
42. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
43. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse.
von Stackelberg A; Seeger K; Henze G; Eckert C
Leukemia; 2004 Oct; 18(10):1727-8; author reply 1728-9. PubMed ID: 15356653
[No Abstract] [Full Text] [Related]
44. Advances in therapy for childhood non-B-lymphoblastic leukaemia.
Rivera GK
Baillieres Clin Haematol; 1994 Jun; 7(2):273-98. PubMed ID: 7803902
[TBL] [Abstract][Full Text] [Related]
45. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
de Bont JM; Holt Bv; Dekker AW; van der Does-van den Berg A; Sonneveld P; Pieters R
Leukemia; 2004 Dec; 18(12):2032-5. PubMed ID: 15483674
[No Abstract] [Full Text] [Related]
46. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
Ko RH; Ji L; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
J Clin Oncol; 2010 Feb; 28(4):648-54. PubMed ID: 19841326
[TBL] [Abstract][Full Text] [Related]
47. Lymphoblastic lymphoma.
Thomas DA; Kantarjian HM
Hematol Oncol Clin North Am; 2001 Feb; 15(1):51-95, vi. PubMed ID: 11253609
[TBL] [Abstract][Full Text] [Related]
48. Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
Krishnan S; Wade R; Moorman AV; Mitchell C; Kinsey SE; Eden TO; Parker C; Vora A; Richards S; Saha V
Leukemia; 2010 Feb; 24(2):450-9. PubMed ID: 20016529
[TBL] [Abstract][Full Text] [Related]
49. Acute Lymphoblastic Leukemia in Children.
Hunger SP; Mullighan CG
N Engl J Med; 2015 Oct; 373(16):1541-52. PubMed ID: 26465987
[No Abstract] [Full Text] [Related]
50. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.
Pui CH; Pei D; Sandlund JT; Campana D; Ribeiro RC; Razzouk BI; Rubnitz JE; Howard SC; Hijiya N; Jeha S; Cheng C; Downing JR; Evans WE; Relling MV; Hudson M
J Clin Oncol; 2005 Nov; 23(31):7936-41. PubMed ID: 16258093
[TBL] [Abstract][Full Text] [Related]
51. 'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'.
Schrappe M; Nachman J; Hunger S; Schmiegelow K; Conter V; Masera G; Pieters R; Pui CH
Leukemia; 2010 Feb; 24(2):253-4. PubMed ID: 20145664
[No Abstract] [Full Text] [Related]
52. Acute leukaemias.
Stevens RF
Baillieres Clin Haematol; 1991 Apr; 4(2):429-58. PubMed ID: 1912666
[No Abstract] [Full Text] [Related]
53. Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland.
Jatczak-Gaca A; Styczynski J; Koltan A; Debski R; Pogorzala M; Wysocki M
Leuk Lymphoma; 2015 Jul; 56(7):2212-4. PubMed ID: 25547656
[No Abstract] [Full Text] [Related]
54. How we approach Philadelphia chromosome-positive acute lymphoblastic leukemia in children and young adults.
Slayton WB; Schultz KR; Silverman LB; Hunger SP
Pediatr Blood Cancer; 2020 Oct; 67(10):e28543. PubMed ID: 32779849
[TBL] [Abstract][Full Text] [Related]
55. Acute lymphoblastic leukemia.
Chan KW
Curr Probl Pediatr Adolesc Health Care; 2002 Feb; 32(2):40-9. PubMed ID: 11951089
[TBL] [Abstract][Full Text] [Related]
56. Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
Raetz EA; Cairo MS; Borowitz MJ; Lu X; Devidas M; Reid JM; Goldenberg DM; Wegener WA; Zeng H; Whitlock JA; Adamson PC; Hunger SP; Carroll WL
Pediatr Blood Cancer; 2015 Jul; 62(7):1171-5. PubMed ID: 25732247
[TBL] [Abstract][Full Text] [Related]
57. Early T-cell precursor leukemia/lymphoma in adults and children.
Allen A; Sireci A; Colovai A; Pinkney K; Sulis M; Bhagat G; Alobeid B
Leuk Res; 2013 Sep; 37(9):1027-34. PubMed ID: 23827350
[TBL] [Abstract][Full Text] [Related]
58. Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.
Mullighan CG; Jeha S; Pei D; Payne-Turner D; Coustan-Smith E; Roberts KG; Waanders E; Choi JK; Ma X; Raimondi SC; Fan Y; Yang W; Song G; Yang JJ; Inaba H; Downing JR; Leung WH; Bowman WP; Relling MV; Evans WE; Zhang J; Campana D; Pui CH
Blood; 2015 Dec; 126(26):2896-9. PubMed ID: 26527677
[No Abstract] [Full Text] [Related]
59. Cutaneous squamous cell carcinoma following treatment for acute lymphoblastic leukaemia.
Morland BJ; Radford M
Med Pediatr Oncol; 1993; 21(2):150-2. PubMed ID: 8433682
[TBL] [Abstract][Full Text] [Related]
60. Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival.
Tjønnfjord GE; Gedde-Dahl T; Heldal D; Brinch L
Leukemia; 2007 Oct; 21(10):2203-4. PubMed ID: 17525727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
